Drug profile · INN
filgrastim-txid
NYPOZI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
filgrastim-txid (NYPOZI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN filgrastim-txid
Brand NYPOZI
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is filgrastim-txid?
filgrastim-txid (NYPOZI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for filgrastim-txid?
NYPOZI is a marketed brand name for filgrastim-txid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of filgrastim-txid?
filgrastim-txid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.